Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Context Therapeutics Q2 EPS $(0.25)

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.
byBenzinga Newsdesk
August 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Sanofi Shares Up 1% Premarket; Co on Sunday Announced it Will Not Bid for Horizon Therapeutics

By Charles Gross
December 12, 6:40 AM
Sanofi S.A. ("Sanofi") regularly evaluates a wide variety of business development opportunities and this has included the evaluation of a possible transaction involving Horizon. As transaction price expectations do not meet our value creation criteria, Sanofi announces it is no longer in discussions with Horizon and it does not intend to make an offer for Horizon.

HZNP

Read More

What’s Going On With Roku Stock?

By Adam Eckert
June 7, 3:18 PM
Roku Inc (NASDAQ: ROKU) shares are trading higher on above-average volume Wednesday amid volatility in growth stocks as the Russell 2000 nears three-month highs. Rosenblatt also released a new note on the stock Wednesday morning.

ROKU